UK MHRA · November 03, 2025

Guidance: Regulatory considerations for therapeutic use of bacteriophages in the UK

Clarifies which regulatory guidelines apply to the development of phage therapeutic products in the UK.

High obligation Sector Pharmaceuticals Clinical Trials & Research UK PharmaceuticalsClinical trials

This publication clarifies which regulatory guidelines should be followed, and which apply, in the development of phage therapeutic products.

Read the official source ↗

Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.